These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 1146571)

  • 1. Observations of the early diuretic response after intravenous administration of bumetanide and furosemide in dogs.
    Olsen UB
    Acta Physiol Scand; 1975 Feb; 93(2):195-201. PubMed ID: 1146571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog.
    Cohen MR; Hinsch E; Vergona R; Ryan J; Kolis SJ; Schwartz MA
    J Pharmacol Exp Ther; 1976 Jun; 197(3):697-702. PubMed ID: 932999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute effects of bumetanide in healthy subjects. A comparative study with furosemide (author's transl)].
    Ortź González A; Méndez Martin A
    Med Clin (Barc); 1979 Mar; 72(6):259-64. PubMed ID: 379471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of bumetanide.
    Frey HH
    Postgrad Med J; 1975; 51 Suppl 6():14-18. PubMed ID: 1197201
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diuretic evaluation of bumetanide (author's transl)].
    Barrientos Guzmán A; Ortuño de Solo MT
    Med Clin (Barc); 1979 Nov; 73(8):338-41. PubMed ID: 522529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furosemide and bumetanide: a study of responses in normal English and German subjects.
    Branch RA; Read PR; Levine D; Elst EV; Shelton J; Rupp W; Ramsay LE
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):538-45. PubMed ID: 1277709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and natriuretic effects of bumetanide and furosemide in the cat.
    Friedman PA; Roch-Ramel F
    J Pharmacol Exp Ther; 1977 Oct; 203(1):82-91. PubMed ID: 909060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diuretic activity of bumetanide in a controlled comparison with furosemide in patients with various degrees of impaired renal function (author's transl)].
    Kampf D; Baethke R
    Arzneimittelforschung; 1980; 30(6):1015-8. PubMed ID: 7191261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of the novel highly potent diuretic 7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid potassium salt.
    Shinkawa T; Yamasaki F; Kikuchi A; Nakakuki M; Nishijima K; Uemura A; Mizota M; Orita Y
    Arzneimittelforschung; 1992 Dec; 42(12):1466-72. PubMed ID: 1337698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open comparison of diuretic effects of piretanide and bumetanide in patients with stable renal transplants.
    Bailey RR
    N Z Med J; 1982 Jan; 95(700):44-5. PubMed ID: 7038567
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of bumetanide on cation and anion transport.
    Lant AF
    Postgrad Med J; 1975; 51 Suppl 6():35-42. PubMed ID: 1105531
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of the effects of furosemide, ethacrynic acid and bumetanide on the lithium clearance and diluting segment reabsorption in humans.
    Beutler JJ; Boer WH; Koomans HA; Dorhout Mees EJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):768-72. PubMed ID: 1738122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of loop diuretics on carbohydrate metabolism and electrolyte excretion.
    Robinson DS; Nilsson CM; Leonard RF; Horton ES
    J Clin Pharmacol; 1981; 21(11):637-46. PubMed ID: 7040494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal effects of bumetanide.
    Higashio T; Abe Y; Yamamoto K
    J Pharmacol Exp Ther; 1978 Oct; 207(1):212-20. PubMed ID: 702342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bumetanide--acute and long term studies of a new high potency diuretic.
    Murdoch WR; Auld WH
    Postgrad Med J; 1975 Jan; 51(591):10-4. PubMed ID: 1161670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.
    Roberts CJ; Homeida M; Roberts F; Bogie W
    Br J Clin Pharmacol; 1978 Aug; 6(2):129-33. PubMed ID: 678389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrolyte excretion patterns. Intravenous and oral doses of bumetanide compared to furosemide.
    Brater DC; Fox WR; Chennavasin P
    J Clin Pharmacol; 1981; 21(11):599-603. PubMed ID: 7338569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some aspects of the renal action and clinical pharmacology of oral bumetanide in man.
    Bourke E
    Postgrad Med J; 1975; 51 Suppl 6():23-26. PubMed ID: 1105529
    [No Abstract]   [Full Text] [Related]  

  • 20. Bumetanide and frusemide: a comparison of dose-response curves in healthy men.
    Ramsay LE; McInnes GT; Hettiarachchi J; Shelton J; Scott P
    Br J Clin Pharmacol; 1978 Mar; 5(3):243-7. PubMed ID: 656269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.